Alzheimer's Disease
Alzheimer's Disease is a progressive neurological disorder that affects memory, thinking, and behavior, often leading to confusion and changes in mood or personality.
ACP-204 for Alzheimer's Disease Psychosis
We are testing the effects of ACP-204 in adults with Alzheimer's disease psychosis to see if it helps improve symptoms compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Alzheimer's Disease Psychosis
Alzheimer's Disease psychosis refers to the presence of hallucinations or delusions in individuals with Alzheimer's, which can significantly impact their behavior and interactions.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 55 and 85 years old?
- Do you have a designated study partner or caregiver?
- Do you live in a stable place and have no plans to change your living arrangements?
- Do you have atrial fibrillation (an irregular heartbeat)?
- Do you have symptomatic orthostatic hypotension (feeling dizzy when standing up)?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Acp-204
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Dr. Ivo Natsov Outpatient Clinic For Individual Practice For Specialized Medical Care In Psychiatry ET
Cherven Bryag, Bulgaria
Higya–DCC OOD
Pazardzhik, Bulgaria
Medical Center Medconsult Pleven OOD
Pleven, Bulgaria
Sponsor: Acadia Pharmaceuticals Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.